Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long Acting Insulin vs Multiple Dose Regimen in Gestational Diabetes
NCT04674332Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gestational diabetes mellitus (GDM) (2 arms), sponsored by Ain Shams University. Primary endpoint: Time needed to achieve glycemic control at 1 year. Started Sep 2019; status: completed.
02
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT04674332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674332.